Palmitoylethanolamide for Chronic Inflammatory Pain Conditions
NCT06273462
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
80
Enrollment
FED
Sponsor class
Conditions
Chronic Pain
Interventions
DRUG:
Palmitoylethanolamide 600mg twice a day
OTHER:
placebo
Sponsor
Navy Medical Center San Diego